Insulet (PODD) Capital Expenditures (2010 - 2026)

Insulet has reported Capital Expenditures for 17 years, with the latest figure at $10.1 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 17.89% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $17.0 million (down 85.23% YoY), and the FY2025 full-year result was $19.2 million, down 84.63% from the prior year.
• Capital Expenditures for Q1 2026 stood at $10.1 million, down from $16.1 million in the prior quarter.
• The five-year high for Capital Expenditures was $53.6 million in Q4 2024, with the low at -$37.8 million in Q4 2023.
• Historically, Capital Expenditures has averaged $10.3 million across 5 years, with a median of $10.5 million in 2023.
• The largest YoY upside for Capital Expenditures was 617.86% in 2023 against a maximum downside of 1612.0% in 2023.
• Insulet's Capital Expenditures stood at $2.5 million in 2022, then sank by 1612.0% to -$37.8 million in 2023, then soared by 241.8% to $53.6 million in 2024, then plunged by 69.96% to $16.1 million in 2025, then tumbled by 37.27% to $10.1 million in 2026.
• The last three Capital Expenditures figures came in at $10.1 million (Q1 2026), $16.1 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.